We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
Cap. Flow
+$19.1M
Cap. Flow %
1.71%
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 19.06%
2 Financials 7.05%
3 Industrials 6.04%
4 Consumer Discretionary 4.74%
5 Healthcare 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCF icon
1801
First Commonwealth Financial
FCF
$2.12B
$25.9K ﹤0.01%
1,274
PATH icon
1802
UiPath
PATH
$5.62B
$25.9K ﹤0.01%
2,380
+337
+16% +$3.6K
FC icon
1803
Franklin Covey
FC
$233M
$25.9K ﹤0.01%
1,054
+150
+17% +$3.42K
MPB icon
1804
Mid Penn Bancorp
MPB
$942M
$25.9K ﹤0.01%
742
ARI
1805
Apollo Commercial Real Estate
ARI
$887M
$25.8K ﹤0.01%
2,418
WK icon
1806
Workiva
WK
$2.94B
$25.8K ﹤0.01%
532
+356
+202% +$18.3K
PLNT icon
1807
Planet Fitness
PLNT
$4.23B
$25.8K ﹤0.01%
494
+366
+286% +$21.5K
MATX icon
1808
Matsons
MATX
$6.37B
$25.8K ﹤0.01%
134
INGN icon
1809
Inogen
INGN
$167M
$25.7K ﹤0.01%
3,980
+1,136
+40% +$7.52K
NECB icon
1810
Northeast Community Bancorp
NECB
$368M
$25.7K ﹤0.01%
925
CLDX icon
1811
Celldex Therapeutics
CLDX
$2.77B
$25.6K ﹤0.01%
689
DLX icon
1812
Deluxe
DLX
$1.19B
$25.6K ﹤0.01%
1,071
+203
+23% +$5.28K
MLKN icon
1813
MillerKnoll
MLKN
$1.5B
$25.6K ﹤0.01%
1,250
+781
+167% +$12.5K
XLY icon
1814
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
$25.6K ﹤0.01%
218
CRSP icon
1815
CRISPR Therapeutics
CRSP
$4.58B
$25.4K ﹤0.01%
465
+296
+175% +$15.6K
UPBD icon
1816
Upbound Group
UPBD
$1.19B
$25.3K ﹤0.01%
1,193
-943
-44% -$17.6K
MDY icon
1817
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$25.3K ﹤0.01%
36
CARE icon
1818
Carter Bankshares
CARE
$756M
$25.2K ﹤0.01%
742
XLI icon
1819
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
$25.2K ﹤0.01%
136
CVCO icon
1820
Cavco Industries
CVCO
$4.39B
$25.2K ﹤0.01%
41
+14
+52% +$7.43K
NATL icon
1821
NCR Atleos
NATL
$3.52B
$25.2K ﹤0.01%
580
UHAL icon
1822
U-Haul Holding Co
UHAL
$14B
$25.1K ﹤0.01%
383
+108
+39% +$5.92K
STAG icon
1823
STAG Industrial
STAG
$7.86B
$25K ﹤0.01%
657
+236
+56% +$9.02K
DGICA icon
1824
Donegal Group Class A
DGICA
$695M
$25K ﹤0.01%
1,325
-1,885
-59% -$32.7K
NEO icon
1825
NeoGenomics
NEO
$1.81B
$24.9K ﹤0.01%
1,708

Similar funds

Versant Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

  • Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
  • Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
  • Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
  • Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
  • Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
  • Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
  • Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.